US FDA approves Novartis' Afinitor to treat adult patients with kidney tumours pharmabiz.com The US Food and Drug Administration (FDA) has approved Novartis' drug Afinitor (everolimus) tablets for the treatment of adult patients with kidney tumours known as renal angiomyolipomas and tuberous sclerosis complex (TSC), who do not require ... Afinitor (Everolimus) Approved For Renal Angiomyolipomas By FDA FDA Expands Everolimus Label FDA Approves Everolimus for Renal Angiomyolipomas |
